New study suggests U.S.-developed HIV antibodies protect animals

LOS ANGELES, Jan. 18 (Xinhua) -- Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study, according to the U.S. National Institutes of Health (NIH).

The study intended to inform development of a preventive HIV vaccine for people.